1. Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.
- Author
-
Espejo-Román, José M., Rubio-Ruiz, Belén, Cano-Cortés, Victoria, Cruz-López, Olga, Gonzalez-Resines, Saúl, Domene, Carmen, Conejo-García, Ana, and Sánchez-Martín, Rosario M.
- Subjects
HYALURONIC acid ,NANOMEDICINE ,CD44 antigen ,NANOPARTICLES ,BINDING sites ,MOLECULAR dynamics ,CELL migration - Abstract
Hyaluronic acid (HA), through its interactions with the cluster of differentiation 44 (CD44), acts as a potent modulator of the tumor microenvironment, creating a wide range of extracellular stimuli for tumor growth, angiogenesis, invasion, and metastasis. An innovative antitumor treatment strategy based on the development of a nanodevice for selective release of an inhibitor of the HA-CD44 interaction is presented. Computational analysis was performed to evaluate the interaction of the designed tetrahydroisoquinoline-ketone derivative (JE22) with CD44 binding site. Cell viability, efficiency, and selectivity of drug release under acidic conditions together with CD44 binding capacity, effect on cell migration, and apoptotic activity were successfully evaluated. Remarkably, the conjugation of this CD44 inhibitor to the nanodevice generated a reduction of the dosis required to achieve a significant therapeutic effect. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF